For: | Bonacini M, Kassamali F, Kari S, Lopez Barrera N, Kohla M. Racial differences in prevalence and severity of non-alcoholic fatty liver disease. World J Hepatol 2021; 13(7): 763-773 [PMID: 34367497 DOI: 10.4254/wjh.v13.i7.763] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v13/i7/763.htm |
Number | Citing Articles |
1 |
Huilian Shi, Fei Qiao, Kaiyue Huang, Weiting Lu, Xinzhuang Zhang, Zhipeng Ke, Yanchi Wu, Liang Cao, Yuanyuan Chen. Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation. Journal of Ethnopharmacology 2022; 296: 115477 doi: 10.1016/j.jep.2022.115477
|
2 |
Somtochukwu Stephen Onwuzo, Asif Ali Hitawala, Antoine Boustany, Prabhat Kumar, Ashraf Almomani, Chidera Onwuzo, Jessy Mascarenhas Monteiro, Imad Asaad. Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study. World Journal of Hepatology 2023; 15(2): 265-273 doi: 10.4254/wjh.v15.i2.265
|
3 |
Kenneth Cusi, Scott Isaacs, Diana Barb, Rita Basu, Sonia Caprio, W. Timothy Garvey, Sangeeta Kashyap, Jeffrey I. Mechanick, Marialena Mouzaki, Karl Nadolsky, Mary E. Rinella, Miriam B. Vos, Zobair Younossi. American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings. Endocrine Practice 2022; 28(5): 528 doi: 10.1016/j.eprac.2022.03.010
|
4 |
Marlen Ivon Castellanos-Fernandez, Shreya C. Pal, Marco Arrese, Juan Pablo Arab, Jacob George, Nahum Méndez-Sánchez. Nonalcoholic Fatty Liver Disease in Latin America and Australia. Clinics in Liver Disease 2023; 27(2): 301 doi: 10.1016/j.cld.2023.01.015
|
5 |
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients 2022; 14(21): 4556 doi: 10.3390/nu14214556
|
6 |
Yasuyuki Komiyama, Utaroh Motosugi, Shinya Maekawa, Leona Osawa, Natsuko Nakakuki, Hitomi Takada, Masaru Muraoka, Yuichiro Suzuki, Mitsuaki Sato, Shinichi Takano, Mitsuharu Fukasawa, Tatsuya Yamaguchi, Hiroshi Onishi, Meng Yin, Nobuyuki Enomoto. Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography. Hepatology Research 2023; 53(3): 208 doi: 10.1111/hepr.13858
|
7 |
Chuwei Yu, Jing Chen, Jin Ren. Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment. Molecular Biology Reports 2022; 49(10): 9841 doi: 10.1007/s11033-022-07503-0
|
8 |
Eftitan Y. Akam, Akua A. Nuako, Afkera K. Daniel, Fatima Cody Stanford. Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention. Current Diabetes Reports 2022; 22(3): 129 doi: 10.1007/s11892-022-01451-6
|
9 |
Banrida Wahlang, Hong Gao, Shesh N. Rai, Rachel J. Keith, Craig J. McClain, Sanjay Srivastava, Mathew C. Cave, Aruni Bhatnagar. Associations between residential volatile organic compound exposures and liver injury markers: The role of biological sex and race. Environmental Research 2023; 221: 115228 doi: 10.1016/j.envres.2023.115228
|
10 |
Ling Yang, Hangkai Huang, Zhening Liu, Jiaqi Ruan, Chengfu Xu. Association of the android to gynoid fat ratio with nonalcoholic fatty liver disease: a cross-sectional study. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1162079
|
11 |
Navya Malladi, Md Jahangir Alam, Subir K. Maulik, Sanjay K. Banerjee. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins & Other Lipid Mediators 2023; 169: 106766 doi: 10.1016/j.prostaglandins.2023.106766
|